INTRODUCING NEW CLEARPATH DS-120 EXAMS!
A 6 second non-invasive eye test will tell you your risk for diabetes.
Screen At-Risk Patients:
• Determines IGT status
• Allows for prevention of diabetes before full onset
• Avoid Complications
• Early disease detection can reduce risk of complications
How It Works:
The Clearpath DS-120 is able to detect lens Auto Fluorescence. When an individual has uncontrolled glucose the DS-120 is able to detect these elevated levels of Auto Fluorescence.
This uncontrolled glucose is caused by Diabetes.